XENE (Xenon Pharmaceuticals) Other Current Liabilities: $7.63 Mil (As of Mar. 2026)


XENE Xenon Pharmaceuticals Inc XENE
25 GF Score
Price $69.95
! 5 Warning Signs
View Full Analysis

What is Xenon Pharmaceuticals Other Current Liabilities?

Xenon Pharmaceuticals XENE +10.38% 25 Other Current Liabilities is $7.63 Mil as of Mar. 2026. GuruFocus rates XENE with a GF Score™ of 25/100. The stock has 5 warning signs investors should review.

Xenon Pharmaceuticals's other current liabilities for the quarter that ended in Mar. 2026 was $7.63 Mil.

Xenon Pharmaceuticals's quarterly other current liabilities increased from Sep. 2025 ($11.10 Mil) to Dec. 2025 ($14.46 Mil) but then declined from Dec. 2025 ($14.46 Mil) to Mar. 2026 ($7.63 Mil).

Xenon Pharmaceuticals's annual other current liabilities increased from Dec. 2023 ($7.43 Mil) to Dec. 2024 ($9.93 Mil) and increased from Dec. 2024 ($9.93 Mil) to Dec. 2025 ($14.46 Mil).

Xenon Pharmaceuticals Other Current Liabilities Related Terms

Xenon Pharmaceuticals Other Current Liabilities Historical Data

* Premium members only.

The historical data trend for Xenon Pharmaceuticals's Other Current Liabilities can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Xenon Pharmaceuticals Other Current Liabilities Chart

Xenon Pharmaceuticals Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
Other Current Liabilities
Get a 7-Day Free Trial Premium Member Only Premium Member Only 5.94 5.82 7.43 9.93 14.46

Xenon Pharmaceuticals Quarterly Data
Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26
Other Current Liabilities Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 5.05 8.55 11.10 14.46 7.63
XENE
25GF Score
Xenon Pharmaceuticals Inc XENE
Other Current Liabilities is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Xenon Pharmaceuticals Other Current Liabilities Calculation

The liability a company needs to pay in the next 12 months, but not assigned to Accounts Payable or Debt. For instance, Wal-Mart (WMT) has accrued wages, salaries, valuation, bonuses, insurance liabilities, accrued tax etc. These are all included in other current liabilities.

What does a Other Current Liabilities of $7.63 Mil mean?
Xenon Pharmaceuticals (XENE) has a Other Current Liabilities of $7.63 Mil as of Mar. 2026. Other current liabilities as record on a company's balance sheet not categorized as standard liabilities. View historical data on Xenon Pharmaceuticals.
Is Xenon Pharmaceuticals' Other Current Liabilities too high?
Xenon Pharmaceuticals' current Other Current Liabilities is $7.63 Mil. Overall, Xenon Pharmaceuticals has a GF Score™ of 25/100, reflecting its overall financial health beyond just this single metric.
How does Xenon Pharmaceuticals' Other Current Liabilities compare to DFTX and LEGN?
Xenon Pharmaceuticals' Other Current Liabilities of $7.63 Mil can be compared against companies in the Biotechnology industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Other Current Liabilities for a Biotechnology company?
A good Other Current Liabilities depends on the Biotechnology industry context. However, Other Current Liabilities should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Other Current Liabilities mean?
A high Other Current Liabilities can signal that a stock is expensive relative to its fundamentals. Other current liabilities as record on a company's balance sheet not categorized as standard liabilities. View historical data on Xenon Pharmaceuticals. Xenon Pharmaceuticals's current Other Current Liabilities is $7.63 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Xenon Pharmaceuticals stock overvalued right now?
Xenon Pharmaceuticals (XENE) has a current Other Current Liabilities of $7.63 Mil. The current Other Current Liabilities is $7.63 Mil. Xenon Pharmaceuticals' overall GF Score™ is 25/100 with 5 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Other Current Liabilities calculated?
Other Current Liabilities is calculated from a company's financial statements. For Xenon Pharmaceuticals (XENE), the current Other Current Liabilities is $7.63 Mil as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Xenon Pharmaceuticals Business Description

Other Exchanges XP0:Germany
Address 200-3650 Gilmore Way, Burnaby, BC, CAN, V5G 4W8
Xenon Pharmaceuticals Inc is a neuroscience-focused biopharmaceutical company committed to improving the lives of people living with neurological and psychiatric disorders. It is advancing a novel product pipeline to address areas of high unmet medical need, including epilepsy and depression. The product candidates of the group include XEN1101, NBI-921352, and XEN496 for Epilepsy and Nav1.7 oral inhibitors for Pain.
25GF Score

Get the complete analysis for XENE

Other Current Liabilities is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

$69.95
Price